Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 17 analysts with 12-month price forecasts for Apellis Pharmaceuticals stock have an average target of 45.59, with a low estimate of 25 and a high estimate of 83. The average target predicts an increase of 128.29% from the current stock price of 19.97.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$25	$45.59	$40	$83
Change	+25.19%	+128.29%	+100.30%	+315.62%

Analyst Ratings

The average analyst rating for Apellis Pharmaceuticals stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	8	7	6	6	6	6
Buy	4	4	4	4	4	4
Hold	7	8	8	8	8	8
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	19	19	18	18	18	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Greg Harrison Scotiabank	Scotiabank	Hold Maintains $30 → $31	Hold	Maintains	$30 → $31	+55.23%	Apr 2, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $50 → $54	Buy	Maintains	$50 → $54	+170.41%	Mar 4, 2025
Luca Issi RBC Capital	RBC Capital	Hold Maintains $26 → $25	Hold	Maintains	$26 → $25	+25.19%	Mar 3, 2025
Salveen Richter Goldman Sachs	Goldman Sachs	Hold Maintains $36 → $32	Hold	Maintains	$36 → $32	+60.24%	Mar 3, 2025
Laura Chico Wedbush	Wedbush	Hold Maintains $30 → $29	Hold	Maintains	$30 → $29	+45.22%	Mar 3, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

881.76M

Increased by 12.85%

from 781.37M

Revenue Next Year

1.07B

Increased by 20.78%

from 881.76M

EPS This Year

-1.00

from -1.60

EPS Next Year

0.26

from -1.00

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	250.65M	66.56M	75.42M	396.59M	781.37M	881.76M	1.07B	1.29B
Revenue Growth	-	-73.44%	13.31%	425.83%	97.02%	12.85%	20.78%	21.13%
EPS	-4.59	-8.84	-6.15	-4.45	-1.60	-1.00	0.26	1.70
EPS Growth	-	-	-	-	-	-	-	556.83%
Forward PE	-	-	-	-	-	-	77.05	11.73
No. Analysts	-	-	-	-	-	23	22	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	989.0M	1.3B	1.9B
Avg	881.8M	1.1B	1.3B
Low	764.3M	848.4M	1.0B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	26.6%	41.8%	78.3%
Avg	12.8%	20.8%	21.1%
Low	-2.2%	-3.8%	-4.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.19	1.92	4.96
Avg	-1.00	0.26	1.70
Low	-1.95	-1.16	0.64

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	1,812.1%
Avg	-	-	556.8%
Low	-	-	145.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.